课题基金 / 基金详情

Acquisition of a Next Generation Orbitrap MS

Acquisition of a Next Generation Orbitrap MS
获得下一代 Orbitrap MS
批准号:
8640367
负责人:
Michael A. Freitas
金额:
$57.25万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-07-15 至 2015-07-14

项目摘要

项目成果

Michael A. Freitas的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):在此申请中,我们要求资金购买ThermoScientific下一代Q-LTQ Orbitrap。我们需要这台仪器,因为它的能力非常适合于自下而上,中向下和自上而下的蛋白质表征,有限样品的高灵敏度定量蛋白质组学和翻译后修饰分析。与目前的LTQ Orbitrap Elite相比,新一代混合Orbitrap有几个关键改进,使其能够实现更好的性能:1)质量选择四极杆可用于选择离子用于Orbitrap或离子阱分析,2)离子阱和Orbitrap质量分析仪的并行操作允许显著提高扫描速率,3)HCD电池用于单离子或多路模式的离子积累,4)在MSn分析的任何阶段充分灵活地进行CID, HCD和ETD解离,5)超高场Orbitrap具有先进的瞬态处理,6)新型,高性能前端ETD源和专用内部质量校准。这些改进以及减少的开销导致高分辨率数据采集率高于其他设计,而不会牺牲灵敏度或动态范围。新一代Orbitrap的更快的MS1和MS2联合扫描速率对于高效超高压LC分离的LC- MS/MS至关重要,从而在不损失数据质量的情况下减少蛋白质组学实验时间。这种要求的下一代Q-LTQ Orbitrap对于支持几个主要用户对人体组织进行大规模蛋白质组学的需求至关重要,这些用户的样品有限,灵敏度和吞吐量是关键要求。
英文摘要
DESCRIPTION (provided by applicant): In this application we are requesting funds for the purchase of a ThermoScientific a next-generation Q-LTQ Orbitrap. We are requesting this instrument because its capabilities are well suited for bottom-up, middle-down and top-down protein characterization, high-sensitivity quantitative proteomics of limited samples and post- translational modification analysis. The requested next-generation hybrid Orbitrap has several key improvements over the current LTQ Orbitrap Elite that allow it to achieve better performance: 1) Mass selecting quadrupole available to select ions for Orbitrap or ion trap analysis, 2) Parallel operation of both ion trap and Orbitrap mass analyzers allowing for significantly increased scan rate, 3) HCD cell for ion accumulation in single ion or multiplexed modes, 4) Full flexibility of CID, HCD and ETD dissociations at any stage of MSn analysis, 5) Ultrahigh field Orbitrap with advanced transient processing, 6) Novel, high performance front-end ETD source and dedicated internal mass calibration. These improvements along with reduced overhead result in a high-resolution data acquisition rate greater than other designs without sacrificing sensitivity or dynamic range. The faster combined MS1 and MS2 scan rates of the requested next-gen Orbitrap are essential for LC- MS/MS with high efficiency ultra-high pressure LC separations, resulting in reduced proteomic experiment time without loss of data quality. This requested next-generation Q-LTQ Orbitrap will be critical to support the needs of several Major Users that performing large-scale proteomics on human tissue where samples are limited and sensitivity and throughput are key requirements.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
Concurrent renal amyloidosis and thymoma resulting in a fatal ventricular thrombus in a dog.
并发肾淀粉样变性和胸腺瘤导致狗致命的心室血栓。
DOI: 10.1111/jvim.15062
发表时间: 2018
期刊: Journal of veterinary internal medicine
影响因子: 2.6
作者: [Loewen,JenniferM, Cianciolo,RachelE, Zhang,Liwen, Yaeger,Michael, Ward,JessicaL, Smith,JodiD, LeVine,DanaN]
通讯作者: LeVine,DanaN
DOI: 10.1002/pmic.201700442
发表时间: 2018-06
期刊: Proteomics
影响因子: 3.4
作者: [Jiang T, Hoover ME, Holt MV, Freitas MA, Marshall AG, Young NL]
通讯作者: Young NL
DOI: 10.1016/j.mcpro.2022.100256
发表时间: 2022-07
期刊: MOLECULAR & CELLULAR PROTEOMICS
影响因子: 7
作者: [Johnson, Benjamin S., Chafin, Lexie, Farkas, Daniela, Adair, Jessica, Elhance, Ajit, Farkas, Laszlo, Bednash, Joseph S., Londino, James D.]
通讯作者: Londino, James D.
DOI: 10.1016/j.jbc.2021.101327
发表时间: 2021-11
期刊: The Journal of biological chemistry
影响因子: --
作者: [Ellenbogen JB, Jiang R, Kountz DJ, Zhang L, Krzycki JA]
通讯作者: Krzycki JA
Identification of Histone Modification Interaction Networks
  • 批准号:
    7570472
  • 项目类别:
  • 资助金额:
    $26.25万
  • 财政年份:
    2009
  • 负责人:
    Michael A. Freitas
  • 依托单位:
Identification of Histone Modification Interaction Networks
  • 批准号:
    7897917
  • 项目类别:
  • 资助金额:
    $26.25万
  • 财政年份:
    2009
  • 负责人:
    Michael A. Freitas
  • 依托单位:
Acquisition of a high-throughput high mass accuracy MS for chromatin research
  • 批准号:
    7215080
  • 项目类别:
  • 资助金额:
    $50.0万
  • 财政年份:
    2007
  • 负责人:
    Michael A. Freitas
  • 依托单位:
Assays for Screening Histone Modification in Cancer
  • 批准号:
    6941103
  • 项目类别:
  • 资助金额:
    $23.55万
  • 财政年份:
    2004
  • 负责人:
    Michael A. Freitas
  • 依托单位:
国内基金
海外基金
分化肌细胞脱细胞ECM-cells sheet 3D 支架构建及其促进容积性肌组织缺损再 生修复应用及机制研究
库否细胞(Kupffer cells)受体PirB/LILRB2在非酒精性脂肪性肝炎中的作用及机制研究
  • 批准号:
    82470907
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2024
  • 负责人:
    余学锋
  • 依托单位:
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
  • 批准号:
    82072862
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2020
  • 负责人:
    徐云升
  • 依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
  • 批准号:
    82070825
  • 项目类别:
    面上项目
  • 资助金额:
    53.0万元
  • 批准年份:
    2020
  • 负责人:
    徐西振
  • 依托单位: